‘Miraculous’ treatments for more patients
David Mooney’s team develops immunotherapies that work across many cancer types
A series of random questions answered by Harvard experts.
David Mooney’s team develops immunotherapies that work across many cancer types
Research highlighting chronic inflammation opens path to treating illness that affects millions of Americans
Study finds most districts already regulate devices. Is the real issue enforcement?
New research shows negative voices are relatively rare in drug approval hearings.
Experts weigh in on whether tech poses threat to critical thinking, pointing to cautionary tales in use of other cognitive labor tools
long read
Findings suggest colibactin may be promising target for disease prevention
4 min read
Sven Beckert’s new history traces complex global evolution of system that continues to shift, disrupt even now
8 min read